Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001615219-19-000010
Filing Date
2019-03-06
Accepted
2019-03-06 17:07:21
Documents
4
Effectiveness Date
2019-03-06

Document Format Files

Seq Description Document Type Size
1 S-8 flks20190306forms-8.htm S-8 96713
2 EXHIBIT 5.1 flks20190306s-8exx51.htm EX-5.1 10210
3 EXHIBIT 23.1 flks20190306s-8exx231.htm EX-23.1 2594
4 cooleya03.jpg GRAPHIC 9853
  Complete submission text file 0001615219-19-000010.txt   118803
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-230104 | Film No.: 19663327
SIC: 2834 Pharmaceutical Preparations